Clonal deletion of tumor-specific T cells by IFN-g confers therapeutic resistance to combination immune checkpoint blockade

ABSTRACT: Clonal deletion of tumor-specific T cells by IFN-g confers therapeutic resistance to combination immune checkpoint blockade

PROVIDER: PRJNA498104 | ENA |

REPOSITORIES: ENA